Radius Health

Radius Health R&D per Employee

Delisted

The R&D Spending per Employee of Radius Health (RDUS) as of Oct 28, 2026 is 44,711.39 USD. In the previous year, R&D Spending per Employee was 53,042.84 USD — a change of -15.71% (lower).

R&D per Employee

44,711.39USD

YoY

-15.71%

Last updated:

R&D Spending per Employee of Radius Health is 2021 44,711.39 USD. R&D Spending per Employee of Radius Health was 2020 53,042.84 USD. It decreases by -15.71% lower compared to the previous year.

The Radius Health R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2015
22,676.85 USD
Jan 1, 2016
35,671.21 USD
Jan 1, 2017
27,590.83 USD
Jan 1, 2018
33,182.00 USD
Jan 1, 2019
38,776.82 USD
Jan 1, 2020
53,042.84 USD
Jan 1, 2021
44,711.39 USD
The Radius Health R&D per Employee history
YEARR&D per EmployeeYoY
44,711.39USD-15.71%
53,042.84USD+36.79%
38,776.82USD+16.86%
33,182.00USD+20.26%
27,590.83USD-22.65%
35,671.21USD+57.30%
22,676.85USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radius Health Stock analysis

What does Radius Health do? Radius Health Inc. is an American pharmaceutical company specializing in the research, development, and marketing of products in the areas of osteoporosis, cancer therapy, and endocrinology. The company was founded in 2003 and is headquartered in Waltham, Massachusetts. The history of Radius Health Inc. began with the discovery of a new compound called Abaloparatide, which was intended for use in the treatment of osteoporosis. The company initiated a Phase III clinical trial to evaluate the efficacy and tolerability of the medication. In 2016, Abaloparatide was approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis. Since then, Radius Health Inc. has evolved into a leading company specializing in improving women's health. The company has expanded its activities to include oncology and endocrinology and relies on innovative technologies and research to provide better treatment options and medications for patients. The business model of Radius Health Inc. is based on the development and marketing of cost-effective and effective products for the treatment of diseases. The company conducts extensive clinical research and strives to develop new drugs and therapies to improve the lives of women. Radius Health Inc. employs an open and agile corporate culture that promotes innovation and prioritizes the needs of patients. The products offered by Radius Health Inc. include a wide range of medications used in the treatment of osteoporosis, breast cancer, and other diseases. Abaloparatide, the company's flagship product, is a recombinant peptide agonist that stimulates bone formation and reduces the risk of fractures in postmenopausal women. Other products include Elacestrant, an investigative drug for the treatment of breast cancer, and RAD1901, a selective estrogen receptor modulator used in the treatment of hormone-dependent cancers. The company is also active in the field of digital health. Radius Health Inc. has developed an augmented reality app that assists doctors and patients in visualizing bone fractures and other conditions. The app is currently being tested in clinical trials and is expected to be widely used in the future. Overall, Radius Health Inc. is known for its innovative research activities and efforts to improve women's health. The company has an experienced and dedicated team of researchers, scientists, and executives working together to create better treatment options for patients. With a strong pipeline of products and a vision for the future of healthcare, Radius Health Inc. is on track to become a leading provider of medical products and services. Radius Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radius Health stock

R&D Spending per Employee of Radius Health is 44,711.39 USD in 2021.

R&D Spending per Employee of Radius Health changed from 53,042.84 USD to 44,711.39 USD, representing a -15.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Radius Health since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Radius Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Radius Health

All Key Metrics — Radius Health